Cargando…

Tonin Overexpression in Mice Diminishes Sympathetic Autonomic Modulation and Alters Angiotensin Type 1 Receptor Response

Background: Tonin, a serine-protease that forms Angiotensin II (AngII) from angiotensinogen, is increased in failing human heart samples. Increased blood pressure (BP) and decreased heart rate (HR) variabilities are associated with higher risk of cardiovascular morbidity. Losartan has been used to r...

Descripción completa

Detalles Bibliográficos
Autores principales: Jara, Zaira Palomino, Icimoto, Marcelo Yudi, Yokota, Rodrigo, Ribeiro, Amanda Aparecida, dos Santos, Fernando, de Souza, Leandro Ezequiel, Watanabe, Ingrid Kazue Mizuno, Franco, Maria do Carmo, Pesquero, Jorge Luiz, Irigoyen, Maria Claudia, Casarini, Dulce Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352559/
https://www.ncbi.nlm.nih.gov/pubmed/30729109
http://dx.doi.org/10.3389/fmed.2018.00365
_version_ 1783390858975903744
author Jara, Zaira Palomino
Icimoto, Marcelo Yudi
Yokota, Rodrigo
Ribeiro, Amanda Aparecida
dos Santos, Fernando
de Souza, Leandro Ezequiel
Watanabe, Ingrid Kazue Mizuno
Franco, Maria do Carmo
Pesquero, Jorge Luiz
Irigoyen, Maria Claudia
Casarini, Dulce Elena
author_facet Jara, Zaira Palomino
Icimoto, Marcelo Yudi
Yokota, Rodrigo
Ribeiro, Amanda Aparecida
dos Santos, Fernando
de Souza, Leandro Ezequiel
Watanabe, Ingrid Kazue Mizuno
Franco, Maria do Carmo
Pesquero, Jorge Luiz
Irigoyen, Maria Claudia
Casarini, Dulce Elena
author_sort Jara, Zaira Palomino
collection PubMed
description Background: Tonin, a serine-protease that forms Angiotensin II (AngII) from angiotensinogen, is increased in failing human heart samples. Increased blood pressure (BP) and decreased heart rate (HR) variabilities are associated with higher risk of cardiovascular morbidity. Losartan has been used to reduce hypertension and, therefore, lowers the risk of fatal and non-fatal cardiovascular events. Determination of tonin's impact on BP and HR variabilities as well as the impact of losartan remain questions to be elucidated. Aim: Evaluation of cardiovascular autonomic profile in transgenic mice overexpressing the rat tonin enzyme TGM'(rton) and the impact of AT1 receptor blocker, losartan. Methods: Male C57BL/6 (WT) and TGM'(rTon) mice were cannulated for recording BP (Windaq, 4 MHz) for 30 min at baseline and 30 min after losartan injection (20 mg/kg). BP and HR variabilities were analyzed in time and frequency domain method. Low-frequency (LF) and high-frequency (HF) components were identified for sympathetic and parasympathetic modulations analysis. Ang I, AngII, and Ang1-7 were quantified by high performance liquid chromatography method. The total enzymatic activity for AngI, AngII, and Ang1-7 formation was evaluated in the heart and plasma by Liquid chromatography mass spectrometry (LC-MS/MS). Results: At the baseline TGM'(rTon) exhibited higher BP, lower cardiac LF, higher cardiac HF, lower LF/HF, and lower alpha index than wild type (WT). After losartan injection, TGM'(rTon) mice presented an additional decrease in cardiac LF and increase in HF in relation to baseline and WT. In the vasculature, losartan caused decreased in BP and LF of systolic BP in WT mice in relation to its baseline. A similar effect was observed in the BP of TGM'(rTon) mice; however, LF of systolic BP increased compared to baseline. Our data also indicates that AT1R receptor signaling has been altered in TGM’(rTon)mice. Interestingly, the dynamics of the renin-angiotensin system kinetics change, favoring production of Ang1-7. Conclusion: Autonomic evaluation of TGM’(rTon) mice indicates an unclear prognosis for diseases that affect the heart. HR variability in TGM’(rTon) mice indicates high risk of morbidity, and sympathetic and parasympathetic modulation indicate low risk of morbidity. The low risk of morbidity could be the biased production of Ang1-7 in the heart and circulation; however, the altered response of AT1R in the TGM’(rTon) remains to be elucidated, as well aswhether that signaling is pro-protection or pro-pathology.
format Online
Article
Text
id pubmed-6352559
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63525592019-02-06 Tonin Overexpression in Mice Diminishes Sympathetic Autonomic Modulation and Alters Angiotensin Type 1 Receptor Response Jara, Zaira Palomino Icimoto, Marcelo Yudi Yokota, Rodrigo Ribeiro, Amanda Aparecida dos Santos, Fernando de Souza, Leandro Ezequiel Watanabe, Ingrid Kazue Mizuno Franco, Maria do Carmo Pesquero, Jorge Luiz Irigoyen, Maria Claudia Casarini, Dulce Elena Front Med (Lausanne) Medicine Background: Tonin, a serine-protease that forms Angiotensin II (AngII) from angiotensinogen, is increased in failing human heart samples. Increased blood pressure (BP) and decreased heart rate (HR) variabilities are associated with higher risk of cardiovascular morbidity. Losartan has been used to reduce hypertension and, therefore, lowers the risk of fatal and non-fatal cardiovascular events. Determination of tonin's impact on BP and HR variabilities as well as the impact of losartan remain questions to be elucidated. Aim: Evaluation of cardiovascular autonomic profile in transgenic mice overexpressing the rat tonin enzyme TGM'(rton) and the impact of AT1 receptor blocker, losartan. Methods: Male C57BL/6 (WT) and TGM'(rTon) mice were cannulated for recording BP (Windaq, 4 MHz) for 30 min at baseline and 30 min after losartan injection (20 mg/kg). BP and HR variabilities were analyzed in time and frequency domain method. Low-frequency (LF) and high-frequency (HF) components were identified for sympathetic and parasympathetic modulations analysis. Ang I, AngII, and Ang1-7 were quantified by high performance liquid chromatography method. The total enzymatic activity for AngI, AngII, and Ang1-7 formation was evaluated in the heart and plasma by Liquid chromatography mass spectrometry (LC-MS/MS). Results: At the baseline TGM'(rTon) exhibited higher BP, lower cardiac LF, higher cardiac HF, lower LF/HF, and lower alpha index than wild type (WT). After losartan injection, TGM'(rTon) mice presented an additional decrease in cardiac LF and increase in HF in relation to baseline and WT. In the vasculature, losartan caused decreased in BP and LF of systolic BP in WT mice in relation to its baseline. A similar effect was observed in the BP of TGM'(rTon) mice; however, LF of systolic BP increased compared to baseline. Our data also indicates that AT1R receptor signaling has been altered in TGM’(rTon)mice. Interestingly, the dynamics of the renin-angiotensin system kinetics change, favoring production of Ang1-7. Conclusion: Autonomic evaluation of TGM’(rTon) mice indicates an unclear prognosis for diseases that affect the heart. HR variability in TGM’(rTon) mice indicates high risk of morbidity, and sympathetic and parasympathetic modulation indicate low risk of morbidity. The low risk of morbidity could be the biased production of Ang1-7 in the heart and circulation; however, the altered response of AT1R in the TGM’(rTon) remains to be elucidated, as well aswhether that signaling is pro-protection or pro-pathology. Frontiers Media S.A. 2019-01-23 /pmc/articles/PMC6352559/ /pubmed/30729109 http://dx.doi.org/10.3389/fmed.2018.00365 Text en Copyright © 2019 Jara, Icimoto, Yokota, Ribeiro, dos Santos, Souza, Watanabe, Franco, Pesquero, Irigoyen and Casarini. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Jara, Zaira Palomino
Icimoto, Marcelo Yudi
Yokota, Rodrigo
Ribeiro, Amanda Aparecida
dos Santos, Fernando
de Souza, Leandro Ezequiel
Watanabe, Ingrid Kazue Mizuno
Franco, Maria do Carmo
Pesquero, Jorge Luiz
Irigoyen, Maria Claudia
Casarini, Dulce Elena
Tonin Overexpression in Mice Diminishes Sympathetic Autonomic Modulation and Alters Angiotensin Type 1 Receptor Response
title Tonin Overexpression in Mice Diminishes Sympathetic Autonomic Modulation and Alters Angiotensin Type 1 Receptor Response
title_full Tonin Overexpression in Mice Diminishes Sympathetic Autonomic Modulation and Alters Angiotensin Type 1 Receptor Response
title_fullStr Tonin Overexpression in Mice Diminishes Sympathetic Autonomic Modulation and Alters Angiotensin Type 1 Receptor Response
title_full_unstemmed Tonin Overexpression in Mice Diminishes Sympathetic Autonomic Modulation and Alters Angiotensin Type 1 Receptor Response
title_short Tonin Overexpression in Mice Diminishes Sympathetic Autonomic Modulation and Alters Angiotensin Type 1 Receptor Response
title_sort tonin overexpression in mice diminishes sympathetic autonomic modulation and alters angiotensin type 1 receptor response
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352559/
https://www.ncbi.nlm.nih.gov/pubmed/30729109
http://dx.doi.org/10.3389/fmed.2018.00365
work_keys_str_mv AT jarazairapalomino toninoverexpressioninmicediminishessympatheticautonomicmodulationandaltersangiotensintype1receptorresponse
AT icimotomarceloyudi toninoverexpressioninmicediminishessympatheticautonomicmodulationandaltersangiotensintype1receptorresponse
AT yokotarodrigo toninoverexpressioninmicediminishessympatheticautonomicmodulationandaltersangiotensintype1receptorresponse
AT ribeiroamandaaparecida toninoverexpressioninmicediminishessympatheticautonomicmodulationandaltersangiotensintype1receptorresponse
AT dossantosfernando toninoverexpressioninmicediminishessympatheticautonomicmodulationandaltersangiotensintype1receptorresponse
AT desouzaleandroezequiel toninoverexpressioninmicediminishessympatheticautonomicmodulationandaltersangiotensintype1receptorresponse
AT watanabeingridkazuemizuno toninoverexpressioninmicediminishessympatheticautonomicmodulationandaltersangiotensintype1receptorresponse
AT francomariadocarmo toninoverexpressioninmicediminishessympatheticautonomicmodulationandaltersangiotensintype1receptorresponse
AT pesquerojorgeluiz toninoverexpressioninmicediminishessympatheticautonomicmodulationandaltersangiotensintype1receptorresponse
AT irigoyenmariaclaudia toninoverexpressioninmicediminishessympatheticautonomicmodulationandaltersangiotensintype1receptorresponse
AT casarinidulceelena toninoverexpressioninmicediminishessympatheticautonomicmodulationandaltersangiotensintype1receptorresponse